Clinical Trial: An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583563) titled 'An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly' on April 27.

Brief Summary: The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.

Study Start Date: May, 2026

Study Type: OBSERVATIONAL

Condition: Acromegaly

Intervention: DRUG: Octreotide subcutaneous depot

Commercially available octreotide subcutaneous depot treatment administered by participants for a maximum duration up to 2 years in the study

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Camurus AB

Disclaimer...